Product Information

TACROLIMUS 0.03% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.1050 per GM under NDC 45802039001. Its NADAC has been published 614 times since Feb 18, 2015.

FDA first approved this application on Dec 8, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TACROLIMUS 0.03% OINTMENT

Tacrolimus
$1.1050per GM

Strength

.3 mg/g

NDC

45802039001

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

TACROLIMUS

Approval Type

New Drug (NDA)

FDA Application

NDA050777

FDA Approved

12/8/2000

TE Code

AB

On Market Since

11/20/2014

Pharmacological Classes

Price Statistics

The NADAC for TACROLIMUS 0.03% OINTMENT has been published 614 times since Feb 18, 2015, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1050 per GM
All-time high$6.5168 (Jun 10, 2015)
All-time low$0.5582 (May 22, 2024)
52-week high$1.1050
52-week low$0.7651
Median price$3.2801
Average price$3.1976
Largest weekly change+50.4% (Mar 22, 2023)
Weeks tracked614
Tracking sinceFeb 18, 2015

Price History

1W

+3.3%

1M

+10.7%

3M

+22.3%

6M

+21.8%

1Y

+34.1%

3Y

-12.8%

5Y

-39.9%

All

-82.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TACROLIMUS 0.03% OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.1050 per GM (NDC 45802039001), effective Nov 18, 2026.

How has the price of TACROLIMUS 0.03% OINTMENT changed over time?

Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 82.5%. It has been tracked across 614 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?

Since Feb 18, 2015, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5582 (May 22, 2024) to a high of $6.5168 (Jun 10, 2015), with a median of $3.2801 per GM.

Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.03% OINTMENT, is $0.5924 per GM — about 46% below TACROLIMUS 0.03% OINTMENT.

Who manufactures TACROLIMUS 0.03% OINTMENT?

TACROLIMUS 0.03% OINTMENT (NDC 45802039001) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.